September 11, 2020
September 4, 2020
Prime Therapeutics Lands No. 3 Spot on Minneapolis/St. Paul Business Journal’s 2020 Top 100 Private Companies List.
August 28, 2020
Prime Therapeutics was named an employer of choice, noted for excellent morale, engagement and retention.
August 14, 2020
August 13, 2020
July 29, 2020
July 28, 2020
Next generation agreements may increase affordability, improve patient outcomes.
July 15, 2020
June 30, 2020
CAR-T celll therapy: Removing, re-engineering and reinfusing the patient's own immune cells, supercharged to become cancer killers.
June 23, 2020
Industry-leading analytics solution, powered by the Artemetrx platform, informs near-term interventions designed to improve health outcomes and lower total cost of care.
June 19, 2020
Albuquerque honored as an employer of choice for excellent morale, engagement and retention.
June 15, 2020
This synopsis looks ahead to the new drugs expecting an FDA decision in the month of July.
June 8, 2020
Alignment Health Plan (AHP) and Florida Blue both recognized for excellence in quality by Pharmacy Quality Alliance. This is the third year in a row that AHP has been recognized; the second year for Florida Blue.
May 15, 2020
May 13, 2020
Delivering value and making Medicare easier to use. A conversation with Rachel Nelson, Vice President and General Manager of Federal Programs for Prime Therapeutics
April 24, 2020
Improved Star ratings for Medicare clients is a measure of Prime’s quality care and service to members.
April 21, 2020
Dedicated Medicaid teams drive value programming for Prime clients.
April 20, 2020
Keeping a close eye on the drug pipeline helped save millions in annual costs and reduced bleeding episodes for a 14-year-old boy with hemophilia.
April 16, 2020
This synopsis looks ahead to the new drugs expecting an FDA decision in the month of May.
April 7, 2020
Prime’s Specialty Monitor® Solution Identifies $5 Million in Projected Savings for Blue Cross and Blue Shield of North Carolina
Actionable insights delivered better and faster than traditional methods.
April 7, 2020
It has hundreds of one-person contact centers across the country (most agents work safely from home and still meet the needs of members with empathy and technology).
March 19, 2020
Prime showcases how leveraging data, technology and intelligence contains costs and improves the patient experience.
March 18, 2020
This will be the third, high cost drug treatment option emerging for spinal muscular atrophy in less than five years; many more are in the pipeline.
March 13, 2020
This synopsis looks ahead to the new drugs expecting an FDA decision in the month of April.
February 14, 2020
This synopsis looks ahead to the new drugs expecting an FDA decision in the month of March. March 2020 decisions.
February 19, 2020
Prime’s employee volunteers and financial contributions make a difference.
January 15, 2020
A synopsis of the new drugs expecting an FDA decision in the month of February.
January 20, 2020
Trikafka’s triple combination therapy may cover 90% of patients with cystic fibrosis.
January 22, 2020
Ubrelvy™ brings a new treatment option (oral) to a new drug class (CGRP) for patients with migraine. Prime stays on top of the drug pipeline so our clients don’t fall behind.